Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease

Research output: Contribution to journalReview article

Abstract

The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic features or damage and clinical and cognitive function. This article provides a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer's disease (AD) biomarkers on clinical and cognitive outcomes among individuals with preclinical AD. Current evidence shows that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.

Original languageEnglish (US)
Pages (from-to)65-77
Number of pages13
JournalPsychiatric Clinics of North America
Volume41
Issue number1
DOIs
StatePublished - Mar 1 2018

Fingerprint

Cognitive Reserve
Alzheimer Disease
Cognition
Longitudinal Studies
Biomarkers
Prospective Studies
Brain

Keywords

  • Alzheimer disease
  • Amyloid
  • Atrophy
  • Biomarkers
  • Cognitive reserve
  • Mild cognitive impairment
  • Tau

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{ea43554257954bc89f91edf23cef0ded,
title = "Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease",
abstract = "The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic features or damage and clinical and cognitive function. This article provides a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer's disease (AD) biomarkers on clinical and cognitive outcomes among individuals with preclinical AD. Current evidence shows that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.",
keywords = "Alzheimer disease, Amyloid, Atrophy, Biomarkers, Cognitive reserve, Mild cognitive impairment, Tau",
author = "Anja Soldan and Corinne Pettigrew and Marilyn Albert",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.psc.2017.10.006",
language = "English (US)",
volume = "41",
pages = "65--77",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease

AU - Soldan, Anja

AU - Pettigrew, Corinne

AU - Albert, Marilyn

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic features or damage and clinical and cognitive function. This article provides a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer's disease (AD) biomarkers on clinical and cognitive outcomes among individuals with preclinical AD. Current evidence shows that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.

AB - The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic features or damage and clinical and cognitive function. This article provides a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer's disease (AD) biomarkers on clinical and cognitive outcomes among individuals with preclinical AD. Current evidence shows that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.

KW - Alzheimer disease

KW - Amyloid

KW - Atrophy

KW - Biomarkers

KW - Cognitive reserve

KW - Mild cognitive impairment

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=85041311274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041311274&partnerID=8YFLogxK

U2 - 10.1016/j.psc.2017.10.006

DO - 10.1016/j.psc.2017.10.006

M3 - Review article

C2 - 29412849

AN - SCOPUS:85041311274

VL - 41

SP - 65

EP - 77

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 1

ER -